MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage for up to 28 days only based on manufacturer's stability data.

Provenance

This compatibility recommendation is derived from Januvia 100mg tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 25mg tablets (Pfizer Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Arcoxia 30mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Arcoxia 60mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Arcoxia 90mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Arcoxia 120mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aromasin 25mg tablets (Pfizer Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Ezetrol 10mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Data shows stability for up to 4 weeks.

Provenance

This compatibility recommendation is derived from Truvada 200mg/245mg tablets (Gilead Sciences Ltd).

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.